Can this be a game changer? Will we hear positive news on partnership, institutional investment and update on RadioGel that may boost the share price? Or will this be just an ordinary Q2 conference call? The market view is bearish however this may change tomorrow. Let us find out what happens.
Safety By Design - Skin Cancer program
Isotope sales at record level this quarter from Russian partner. Local accelerator is still down.
$8-$13 million off of Cedars LA deal when complete. Instlation of accelerator. Will know in September
Meeting in Europe and Russia scheduled for September for more business.
Things do look to improve in the next quarter and forward. Share price is to low in my opinion and Jim's.
I will be holding onto my stock and adding when finances and SP are right.
I believe we will hear positive news on some of those fronts you mention Zippy. I will not speculate what sort of short term impacts it might have to the share price. The company should be taking advantage of increased share prices to raise capital although I would like them to hold off as much as possible for as long as possible. We just can't lie to ourselves you know. The ADMD product and service to the marketplace is a very good one but it will take time. The stock should not be at $.20 a share either as in the past. I am looking forward to seeing expectations start to allign for them and market expansion in their isotope business. They will be RadioGel users someday after all.
Yes, you are correct. The market is fearing dilution which is why we see a bearish trend, however I believe the dilution factor is already priced in and there is no way that management will dilute at this share price. I assume that may come in with a major pop in share price after FDA approves RadioGel. I still hold my projection of 0.25 by the end of this year which is nearly 5 times the current price. This is a very attractive price with so much potential. I predict major volume tomorrow (2M+) with new investors onboard. Can't wait for the call.